These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8379404)

  • 1. Destruction of follicular dendritic cells in murine acquired immunodeficiency syndrome (MAIDS).
    Masuda A; Burton GF; Fuchs BA; Szakal AK; Tew JG
    Adv Exp Med Biol; 1993; 329():411-6. PubMed ID: 8379404
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of follicular dendritic cells in murine-acquired immunodeficiency syndrome.
    Masuda A; Burton GF; Szakal AK; Tew JG
    Lab Invest; 1995 Oct; 73(4):511-20. PubMed ID: 7474923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
    Harvie P; Omar RF; Dusserre N; Désormeaux A; Gourde P; Tremblay M; Beauchamp D; Bergeron MG
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):451-61. PubMed ID: 8757421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular dendritic cell function and murine AIDS.
    Masuda A; Burton GF; Fuchs BA; Bhogal BS; Rupper R; Szakal AK; Tew JG
    Immunology; 1994 Jan; 81(1):41-6. PubMed ID: 8132218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of quinolinic acid in the murine AIDS model of retrovirus-induced immunodeficiency: implications for neurotoxicity and dendritic cell immunopathogenesis.
    Espey MG; Tang Y; Morse HC; Moffett JR; Namboodiri MA
    AIDS; 1996 Feb; 10(2):151-8. PubMed ID: 8838702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lithium in murine immunodeficiency virus infected animals.
    Gallicchio VS; Cibull ML; Hughes NK; Tse KF
    Pathobiology; 1993; 61(3-4):216-21. PubMed ID: 8216844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique subset of normal murine CD4+ T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS.
    Holmes KL; Morse HC; Makino M; Hardy RR; Hayakawa K
    Eur J Immunol; 1990 Dec; 20(12):2783-7. PubMed ID: 1980114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antigen receptor signaling in B cells from mice with a retrovirus-induced acquired immunodeficiency syndrome.
    Selvey LA; Morse HC; June CH; Hodes RJ
    J Immunol; 1995 Jan; 154(1):171-9. PubMed ID: 7995937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological changes of thymus in retrovirus-induced murine acquired immunodeficiency syndrome (MAIDS).
    de Leval L; Deprez M; Colombi S; Humblet C; Defresne MP; Boniver J; Moutschen M
    Pathol Res Pract; 1995 Jul; 191(6):506-12. PubMed ID: 7479371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
    Akarid K; Pocidalo MA; Desforges B; Sinet M
    Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387.
    Sklan EH; Gazit A; Priel E
    Virology; 2000 Dec; 278(1):95-102. PubMed ID: 11112485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
    Green KA; Noelle RJ; Durell BG; Green WR
    J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression.
    Beilharz MW; Sammels LM; Paun A; Shaw K; van Eeden P; Watson MW; Ashdown ML
    J Immunol; 2004 Apr; 172(8):4917-25. PubMed ID: 15067071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
    Hersh EM; Funk CY; Petersen EA; Ryschon KL; Mosier DE
    Int J Immunopharmacol; 1993 Feb; 15(2):137-43. PubMed ID: 8385652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections.
    Silva JS; Barral-Netto M; Reed SG
    Am J Trop Med Hyg; 1993 Nov; 49(5):589-97. PubMed ID: 8250098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome.
    Simard C; Jolicoeur P
    Science; 1991 Jan; 251(4991):305-8. PubMed ID: 1987646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of NK-1.1 antigen is induced by infection with murine AIDS virus.
    Makino M; Winkler DF; Wunderlich J; Hartley JW; Morse HC; Holmes KL
    Immunology; 1993 Oct; 80(2):319-25. PubMed ID: 8262561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and phenotypic lymphocyte population changes in the mesenteric lymph nodes of murine-AIDS infected mice.
    Lopez MC; Huang DS; Way DL; Watson RR
    Adv Exp Med Biol; 1995; 371B():1039-42. PubMed ID: 7502748
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA; Noelle RJ; Green WR
    Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.